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Background
Besides nitric oxide, carbon monoxide (CO) also acti-
vates soluble guanylyl cyclase (sGC). CO as well as the
CO-donor CORM-2 have been shown to possess vasodi-
latory properties. Whether these vasodilatory properties
by CO can be attributed to sGC activation is still a mat-
ter of debate. The aim of this study was to examine the
involvement of sGC and its different subunits in CO
and CORM-2 induced vasodilatation within different
vascular tissues.
Materials and methods
Isometric tension recordings were performed using mice
isolated aortic rings, femoral artery ring segments as
w e l la sc o r p o r ac a v e r n o s a( C C ) .T ob ea b l et od i s t i n -
guish between the different sGC subunits we evaluated
responses to saturated CO solutions and CORM-2 in
both sGCa1
-/- and sGCb1
KI/KI mice and their wild-type
controls.
Results
Saturated CO solution was unable to relax mice iso-
lated blood vessels, whereas it induced concentration-
dependent relaxations in mice CC. In CC of wild-type
mice, the response to CO was completely inhibited by
the sGC inhibitor ODQ. The involvement of sGC in
the CO-induced corporal relaxation was further con-
firmed by the loss of response to CO in CC isolated
from sGCb1
KI/KI mice. Moreover, the vasodilatory
responses of CO in the corporal tissue of sGCa1
-/-
mice were strongly inhibited although not completely
abolished. In contrast to CO, CORM-2 was able to
relax all vascular tissues examined in the present
study, although ODQ only partially blocked the
response to CORM-2 in the aorta. Interestingly ODQ
did not affect the CORM-2 induced relaxation in the
femoral arteries and the CC, indicating that sGC is not
involved, which was confirmed using the transgenic
mice.
Conclusion
This study clearly illustrates that the molecular
mechanism of CORM-2 induced vasorelaxation differs
from that of CO induced vasorelaxation. While the CO
induced vasorelaxation depends on activation of sGC,
primarily the sGCa1b1 heterodimer, the vasorelaxing
properties of CORM-2 are only partially dependent or
even completely independent upon sGC activation.
The observation that CO is more effective in relaxing
CC tissues than other cardiovascular tissues investi-
gated in the present study suggests that the heme-oxy-
genase/CO pathway may present a potential new target
for therapeutic approaches towards erectile
dysfunction.
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